Park Ha Biological Technology is trading at $2.65, up 11.81% in after-hours trading, with no credible company-specific announcement explaining the rebound.

  • It closed at $2.37 on September 16, 2026.
  • Earlier coverage linked the regular-session decline to negative regulatory news.
  • The $2.97 million PIPE financing was announced September 11, not September 16; the broader market was mixed.